Business in the Burbs

Progenics out of compliance with Nasdaq rule

December

Progenics Pharmaceuticals Inc., an Eastview-based biotech company, said that it has received a letter from the Nasdaq Stock Market indicating that the company is out of compliance with a rule requiring that listed companies have at least three independent members on their audit committees. Progenics said its audit committee has only two independent members. The company added that it is looking to add a qualified candidate to the committee and regain compliance with the rule.

This entry was posted on Thursday, December 11th, 2008 at 5:29 pm by Jay Loomis. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Uncategorized

Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.